Introduction
The metabolic syndrome (MetSyn) is estimated to be prevalent in 30% of the US population. Data from the National Health and Nutrition Examination Survey (NHANES) III have shown that more than 47 million people in the United States have MetSyn (1) . According to the National Cholesterol Education Program: Adult Treatment Panel III (NCEP ATP III) criteria, MetSyn is defined by the presence of three or more of the following traits: central obesity, low high-density protein (HDL) cholesterol, hypertriglyceridaemia, elevated blood pressure (BP) and impaired glucose metabolism (2) .
Individuals with MetSyn may have a higher burden of subclinical carotid atherosclerosis, irrespective of age, gender and ethnicity (3) . Moreover, it is well known that MetSyn is associated strongly with an increased risk of cardiovascular diseases (CVD) and stroke (4, 5) . In the Northern Manhattan Study (NOMAS), comprised predominantly of Caribbean Hispanics, MetSyn was associated with a significantly increased risk of ischaemic stroke with differential effects of gender and ethnicity (6) . Similarly, MetSyn was associated with an increased risk of stroke in predominantly Caucasian cohorts such as NHANES III (4), Framingham (5) , ARIC (7) , a cohort of elderly Finnish people (8) , and different components of MetSyn were analysed in subjects with insulin resistance (9) .
Carotid artery stiffness (STIFF) is a measure of the arterial ability to expand and contract with cardiac pulsation and relaxation (10) . Increased stiffness is a common pathological precursor that leads to CVD and stroke (11) . Recently, arterial stiffness has been measured from the carotid arteries using high-resolution B-mode ultrasound (12) and introduced as a novel risk factor for vascular events (13) . Increased carotid stiffness has been observed in patients with type-2 diabetes, and a marginal increase has also been reported in patients with MetSyn (14) .
Information regarding the association between MetSyn and arterial stiffness among women and men from diverse ethnic backgrounds is limited. The objective of our study was to investigate this association in an elderly multi-ethnic cohort of stroke-free individuals.
Subjects and methods

Study population
The NOMAS is a prospective cohort study of stroke risk factors in a multi-ethnic, urban population of northern Manhattan. In 2000, the population numbered almost 260 000 according to the US census, and 40% were aged 439 years, 20% were African-American, 63% were Hispanic and 15% were Caucasian. NOMAS represents the underlying ethnic mix in this community. The methodology for the NOMAS study has been described previously (15) . The study was approved and written consent was obtained from the Institutional Review Board at Columbia University Medical Center. Standardised questions were adapted from the validated Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System (16) .
The NOMAS cohort is comprised of 3298 stroke-free subjects who were enrolled between 1993 and 2001. Carotid ultrasound imaging was initiated after standardisation of the procedure and was limited to a sample of those who were not enrolled at home (11%). High-resolution carotid ultrasonography imaging for carotid stiffness was performed in 1133 individuals. Sensitivity analyses using imputed data for the entire cohort (n 5 3298) did not show a significant selection bias.
Exposure assessment: metabolic syndrome
The primary exposure of interest was MetSyn as diagnosed by the third report of the NCEP ATP III (2) . A working definition of MetSyn includes at least three of the following abnormalities:
Waist circumference 440Á8 in men and 435Á2 in women. Serum triglyceride level of at least 150 mg/dl. High-density protein cholesterol level of o40 mg/dl in men and o50 mg/dl in women. Blood pressure of at least 130/85 mmHg or previously diagnosed hypertension. Serum glucose level of at least 110 mg/dl. Blood pressure was obtained from the right brachial artery after a 10-min rest in a supine position (Dinamap Pro100, Critikon Inc., Tampa, FL, USA). Blood pressure was measured twice, before and after each examination, and averaged.
Fasting blood specimens were analysed at the Core Laboratory to determine glucose, HDL and triglycerides as described previously (16) . The inter-assay coefficients of variation in our laboratory were 2% for total cholesterol, 4% for triglycerides and 3% for HDL (17) . Fasting serum glucose was measured according to standard procedures using a glucose dehydrogenase method (18) .
Outcome assessment: carotid stiffness
Carotid ultrasound imaging High-resolution carotid ultrasonography was performed on a GE LOGIQ 700 system (GE Healthcare, Milwaukee, WI) using a multifrequency 9/13 MHz linear array transducer. Both internal and common carotid arteries as well as bifurcations were imaged in transverse (short axis) and longitudinal planes (anterior, lateral and posterior views) using standardised scanning and reading protocols (19) . The two independent study sonographers (who were also the readers) performed the scans on all subjects under standardised conditions. Our carotid intimamedia thickness (IMT) reliability study demonstrated a high reproducibility (19) . In a sample of 88 stroke-free community subjects, the mean absolute difference of carotid IMT between two readers was 0Á1970Á36 mm, with a variation coefficient of 7Á5%, a correlation coefficient of 0Á77 and a per cent error of 10Á6%. The intrareader mean absolute IMT difference was 0Á0770Á04 mm, with a variation coefficient of 5Á4%, a correlation coefficient of 0Á94 and a per cent error of 5Á6%.
Ultrasound image acquisition
Carotid images were divided into three segments using the lateral extent of each carotid segment as defined relative to the tip of the flow divider, the most clearly defined anatomic reference where blood flow divides in the carotid bifurcation. The segments were as follows: Segment 1, the near and far walls of the arterial segment extending from 10 to 20 mm proximal to the tip of the flow divider into the common carotid artery (CCA); Segment 2, the near and far walls of the carotid bifurcation beginning at the tip of the flow divider and extending 10 mm proximal to the flow divider tip; and Segment 3, the near and far walls of the proximal 10 mm of the internal carotid artery. STIFF was measured as a part of the carotid IMT protocol (19) . The intraluminal diameters of 10 mm of the right CCA below the origin of the carotid bulb (Segment 1) were analysed. Both the near and the far wall interfaces defining the blood-intima boundaries were maximised and clearly depicted on B-mode images ( Fig. 1a ). M-mode images were obtained in orientations perpendicular to the arterial walls and were adjusted for the clearest representation of the CCA walls throughout the cardiac cycles ( Fig. 1b) .
Image processing and reading protocol
The offline measurement of STIFF was performed using image pro image analysis software (Microsoft Corporation, Redmond, WA) on a specially designed reading station. The bestvisualised blood-intima boundaries from up to 10 M-mode cardiac cycles were traced and the systolic diameter (SD) and diastolic diameter (DD) were automatically computed, averaged and stored in a data file. The high reliability of the SD and DD measurements between the two readers in our laboratory was reported previously (12) . The inter-reader correlation coefficients were 0Á96 for SD and 0Á95 for DD.
Carotid stiffness calculation
The stiffness of an artery segment is a reflection of the mechanical stress affecting the arterial wall during the cardiac cycle (10) . Strain was defined as the amount of deformation relative to the unstressed state and expressed as per cent change in the arterial diameter: Strain 5 (SDÀDD)/DD. STIFF was calculated using the following formula: Stiffness (b) 5 Ln (SBP/DBP)/Strain, where SBP and DBP are brachial systolic and diastolic BP (10, 11) .
Covariate assessment
All subjects completed a comprehensive in-person assessment of sociodemographics, vascular risk factors, medical history and medication use including lipid-lowering agents, insulin, oral hypoglycaemic agents and antihypertensive agents. Ethnicity was defined by self-identification, and categorised as Hispanic, Non-Hispanic-Caucasian and Non-Hispanic-African-American. Smoking was assessed by self-report and categorised as never, former and current. Education level was used to determine the socioeconomic status.
The presence of carotid plaque and IMT was determined at the time of STIFF assessments. Plaque was defined as an area of focal wall thickening or protrusion in the lumen that was at least 50% more than the surrounding wall thickness (20) Data were collected on the presence of plaque (yes or no), the locations of plaques (internal carotid artery, carotid bifurcation and CCA) and the number of plaques at any of the carotid artery segments and categorised as 0, 1 or 41. Carotid IMT is expressed as a composite measure of the mean IMT measured in 12 specified carotid segments (the near and the far wall of the right and the left common carotid artery, carotid bifurcation and internal carotid artery).
Statistical analyses
The mean and standard deviation (SD) values for continuous variables and the proportions for categorical variables were calculated and stratified by the MetSyn status. t-tests and w 2 -tests were used to examine the associations between MetSyn and the continuous and categorical variables, respectively.
STIFF was log transformed to satisfy normality assumptions and was analysed as the dependent variable. Two multiple linear regression models were conducted to examine the association between STIFF and (1) MetSyn (presence vs. absence), and (2) the MetSyn components were entered simultaneously as independent variables. Multivariate models were adjusted for sociodemographics (age, gender and ethnicity), high school education, current smoking, presence of carotid plaque and IMT. The results were considered significant at a 5 0Á05. SAS version 9Á1 (SAS institute, Cary, NC) was used for all statistical analyses.
Results
In the cohort of 1133 subjects, the mean age was 6579 years; 61% were women, 58% were Hispanics, 22% were African-American and 20% were Caucasian. The prevalence of MetSyn was 49%, and differed by gender (39% in men and 55% in women, Po0Á0001) as well as ethnicity (56% in Hispanics, 41% in African-Americans and 39% in Caucasians, Po 0Á0001). Table 1 shows the demographics of the study population overall and stratified by MetSyn. There were differences in the use of lipid-lowering agents (17% with MetSyn vs. 9% without MetSyn,), insulin (5% with MetSyn vs. 1% without MetSyn), oral hypoglycaemic agents (15% with MetSyn vs. 4% without MetSyn), and antihypertensive agents (49% with MetSyn vs. 29% without MetSyn) between the two groups.
A B Fig. 1 (a The MetSyn components (overall and by gender) are presented in Fig. 2(a) . Women were more likely to have a greater (gender-specific) waist circumference value (Po0Á0001). No other gender differences were found in the MetSyn components ( Fig. 2a ). Caucasians were least likely to have elevated BP and high levels of serum glucose compared with Hispanics and African-Americans (Fig. 2b) . Overall, the prevalence of increased waist circumference was the highest among African-Americans and the lowest among Caucasians. Moreover, Hispanics showed a higher prevalence of high levels of triglycerides and low levels of HDL compared with the other two groups.
The carotid artery diameters, stiffness, presence of carotid plaque and IMT are presented in Table 2 . Diastolic diameter and logSTIFF were positively associated with MetSyn (Po0Á05). In the multivariate model, MetSyn remained significantly associated with increased logSTIFF after adjustment for age, gender, ethnicity, current smoking, high-school education, presence of carotid plaque and IMT and medications (parameter estimate b 5 0Á100, P 5 0Á01). Age was the only other covariate that was independently associated with STIFF (b 5 0Á012, Po0Á0001). No other covariates such as current smoking, male gender, high-school education, carotid plaque, carotid IMT and race-ethnicity were significantly associated with STIFF. Also, no significant interaction was observed between MetSyn and gender or between MetSyn and race-ethnicity (data not shown).
In the adjusted multiple linear regression model of the individual MetSyn components (Table 3) , a wider waist circumference and an increased BP were significantly associated with a mean increase in the logSTIFF of 0Á130 (P 5 0Á002) and 0Á185 (P 5 0Á0003), respectively.
Discussion
In this cross-sectional study, we have demonstrated a significant association between MetSyn and STIFF in a multi-ethnic population-based cohort. This relationship is independent of gender and ethnicity. In addition, it was independent of the presence of carotid plaque and IMT, and of lipid-lowering and BP-lowering agents that could have had an effect on artery wall function (21, 22) . Our results indicate that individuals with MetSyn have increased STIFF, which may be an important early marker of subclinical atherosclerosis associated with an increased risk of vascular events.
The functional impairment of the arterial wall may occur in an early stage of the atherosclerotic process before structural wall changes become detectible and before the occurrence of clinical symptoms (23) . Arterial wall stiffness may also be a distinct phenotype of atherosclerosis and completely independent of the presence of atherosclerotic plaque or increased IMT (24) . In the present study, the association between MetSyn and STIFF is independent of the presence of carotid plaque and IMT, suggesting that these subclinical markers may indeed be distinct phenotypes of subclinical atherosclerosis. In addition, carotid plaque and IMT may represent a later stage in the evolution of atherosclerotic disease than stiffness. The relationship between arterial stiffness and the risk of ischaemic stroke has been shown previously (25, 26) . However, the number of prospective studies on the association of arterial stiffness and vascular disease is limited and mainly confined to individuals with manifest arterial disease or to patients with end-stage renal disease. We will have an opportunity to investigate the relationship of STIFF and the risk of stroke in a stroke-free population in the prospective part of our study after accumulating a sufficient number of follow-up years.
We have also demonstrated an association between MetSyn and ischaemic stroke risk in NOMAS (6) . Recently, we have also reported an independent association between MetSyn and subclinical carotid atherosclerosis as measured by carotid plaque presence and thickness (3) . The current study extends our previous results by showing that MetSyn is associated not only with impairment of arterial wall structure but also with wall function, independent of plaque presence and arterial wall thickness. Individuals with MetSyn had a higher burden of subclinical carotid atherosclerosis, suggesting that markers of subclinical carotid atherosclerosis are intermediate conditions before the occurrence of overt vascular diseases. We have also shown that subjects with both MetSyn and endothelial dysfunction, evaluated by brachial artery flow-mediated dilatation, were at a higher risk for CVD than those with either one alone (27) .
There is no consensus on the gold standard for measuring arterial stiffness. Several methods, including ultrasound, applanation tonometry and pulse wave velocity (PWV), have been recommended by the First International Consensus Conference on the Clinical Applications of Arterial Stiffness (28) and by the European Network for Non-invasive Investigation of Large Arteries (29) . Using ultrasound, an association between MetSyn and arterial stiffness has been reported in selected populations with type-2 diabetes, patients with clinical manifestations of arterial disease, those with high-normal blood pressure and impaired glucose regulation and in untreated hypertensive patients (14, 30) . Using PWV, an increase in arterial stiffness was demonstrated in the presence of MetSyn independent of advanced age, elevated BP and accelerated heart rate (31) . MetSyn was shown to be associated with an increased progression of arterial stiffness with age (32) . The rate of PWV increased with age 4Á7 times greater among those with MetSyn (33) . Although the study populations, designs and methods used in these reports have been inconsistent, increased arterial stiffness has been associated with an increased risk of vascular disease despite the different methods used to measure arterial stiffness.
We found that wider waist circumference and elevated blood pressure were MetSyn components most significantly associated with STIFF. In a previous study, high blood pressure was also suggested to be an important MetSyn component associated with an increase in arterial stiffness, as well as high fasting glucose (34) . There is considerable evidence showing that sustained elevations in blood pressure accelerate atherosclerosis, arterial smooth muscle hyperplasia and hypertrophy, and collagen synthesis, thereby increasing arterial stiffness. Increased stiffness appears, however, to be the effect of distending pressure rather than structural changes in the carotid artery wall at least in an early stage of atherosclerosis (35) . Our results support this hypothesis. Obesity may also exert adverse affects on the vascular system by increasing arterial stiffness (36) . Excess body fat, abdominal visceral fat and larger waist circumference have been identified as risk factors for accelerated arterial stiffening (37) . The mechanism behind these associations may be the link between excess body fat, insulin resistance, inflammation and the hormone leptin, which, much like insulin, has been shown to promote smooth muscle cell proliferation and angiogenesis, leading to arterial stiffening (36) . Given the increasing prevalence of obesity in the population and augmented arterial stiffness in obese individuals, these data may have great public health implications. The degree to which vascular stiffening may be reduced with weight loss is unknown, and it may be important for the prevention of stroke and other vascular diseases.
We acknowledge the limitations to this study. This is a crosssectional study; therefore, the effects of MetSyn on STIFF progression, and any treatment response, could not be assessed. In addition, our study is observational, and so only assumptions about possible aetiological relationships can be made. Furthermore, ATP III criteria were used to diagnose MetSyn; other definitions (American Association of Clinical Endocrinologists (38) and World Health Organization) (39) exist, which may make comparisons difficult. However, using different definitions of MetSyn has not been shown to alter the association with artery stiffness (40) . Whether the results from our study can be generalized to other populations is also a possible limitation, particularly because the prevalence of MetSyn and arterial dysfunction among the members of our population is high. However, our data provide information on important US minority groups living together as one community, and there is no evidence to suggest that the physiological processes leading to STIFF in our population are any different from those acting on other communities in the United States.
Conclusion
In a multi-ethnic urban population of stroke-free individuals, a significant association was observed between MetSyn and STIFF, which may, in part, explain a high risk of stroke and CVD. These data may have great public health implications in primary preventive strategies.
